Data Sharing in Health and Science: Something to Fear or Embrace? April 8 2014 Centre for Medical Ethics and Law University of Hong Kong Eric M. Meslin,

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

The U.S. Health Information Technology Agenda – and the Web John W. Loonsk, MD Director of Interoperability and Standards Office of the National Coordinator.
April 2010 MRC Data Sharing Policy Peter Dukes Policy Lead – Data Sharing & Preservation.
4 th Meeting of the EC International Dialogue on Bioethics Copenhagen, June 19 th, 2012 Large research and medical databases in clinical and research multi-centred.
UKRDS Conference 26 February 2009 A Researchers Perspective: the Value and Challenge of Data Professor John Coggins Vice Principal, Life Sciences & Medicine.
A Multimedia Approach to Informed Consent Mildred Z. Solomon, EdD Vice President, Education Development Center, Inc (EDC) Director, EDC’s Center for Applied.
TM The HIPAA Privacy Rule: Safeguarding Health Information in Research and Public Health Practice Centers for Disease Control and Prevention Beverly A.
Copyright ©2011 Freedman Healthcare, LLC All Payer Claims Datasets: Big Data is Coming to Public Health Officials, Providers and Patients Near You StrataRx.
The Community Engagement Studio: Strengthening Research Capacity through Community Engagement Consuelo H. Wilkins, MD, MSCI Executive Director, Meharry.
Rationale for Independent Health Record Banks William A. Yasnoff, MD, PhD, FACMI Managing Partner, NHII Advisors William A. Yasnoff, MD, PhD, FACMI Managing.
Data-Sharing and Governance Consultation ANALYSIS OF RESPONSES.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Anantha Shekhar MD, PhD Indiana University School of Medicine Indiana Clinical and.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
Research Bioethics Consultation: More potential than sequencing genomes Benjamin S. Wilfond MD Seattle Children’s Hospital Treuman Katz Center for Pediatric.
The Nuffield Council on Bioethics Report : The collection, linking and use of data in biomedical research and health care: ethical issues. Martin Richards.
STRENGTHENING HEALTH SYSTEMS Anne Mills DCPP Editor London School of Hygiene and Tropical Medicine.
Objective Vulnerability Assessment Risks for Unauthorized Disclosure of Patient Information Farrokh Alemi, PhD.
Academic Computing Daniella Meeker, PhD Director, Clinical Research Informatics SC-CTSI Assistant Professor of Preventive Medicine and Pediatrics.
Workshop on Health Examination Surveys (HES) Legal and ethical issues Susanna Conti, M. Kanieff, G. Rago Istituto Superiore di Sanità (ISS) (National Public.
1 Puget Sound Health Alliance: a private regional multi-payer database APCD Financing, Governance and Legislative Language Session Natasha Rosenblatt Data.
Tissue Bank Challenges Repository and Pathologist View Elizabeth H. Hammond M.D.
Help us Help you: IRB Policy Updates Susan Bankowski, MS, JD IRB Chair.
Future Use of Stored Samples & Data and the NIH Policy on GWAS and dbGaP NIAID/DAIDS Dione Washington, M.S. -- ProPEP Sudha Srinivasan, Ph.D.-- TRP Tanisha.
Computerized Networking of HIV Providers Workshop Data Security, Privacy and HIPAA: Focus on Privacy Joy L. Pritts, J.D. Assistant Research Professor Health.
Implications for the Use of Tissue in Research P. Pearl O’Rourke, MD Partners HealthCare Boston, MA.
AMERICAN RECOVERY AND REINVESTMENT ACT OF 2009 Health Information Technology for Economic and Clinical Health Act (HITECH Act) Regina.
Security of the Distributed Electronic Patient Record: A Case-Based Approach James G. Anderson, Ph.D. Purdue University.
1 Networked PHR, a framework for personal health applications & services Anne Chapman, Senior Program Manager Personal Health Records, Intel.
Climate Change Uncertainties: Opportunities for Business Innovation? The Business Perspective: UPMC Allison Robinson, PhD, MS Director, Environmental Initiatives.
Availability of scientific and technical environmental data : their effect on decision making mechanisms International Cooperation Consejo Nacional de.
Brought to you by: What is Shared Decision Making? Why is it important?
IndianaCTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Building an Indiana Biorepository Dave A Flockhart Eric Meslin April 19 th, 2010.
Send correspondence to: Bartha Maria Knoppers Chair of Interim Board Centre de recherche en Droit Public Université de Montréal.
OPEN UP! Introduction to handling Freedom of Information requests.
Retha Britz Copyright 2013 All rights reserved for this presentation 1 Other important considerations for RECs Retha Britz.
Barriers and Tools to the Present and Future of Population Genetics Pr Bartha Maria Knoppers Canada Research Chair in Law and Medicine HGM 2006.
Biobanks for research. Ethical and regulatory aspects in human biological samples collections in France Christine NOIVILLE CNRS / Paris 1 University.
Brown Bag Series on Research Faculty Protection of Human Subjects in Research February 10, 2012 Gerberding Hall 142, University of Washington.
C HAPTER 34 Code Blue Health Sciences Edition 4. Confidentiality of sensitive information is an important issue in healthcare. Breaches of confidentiality.
Clinical Research Informatics at the University of Michigan Daniel Clauw M.D. Professor of Medicine, Division of Rheumatology Assistant Dean for Clinical.
TISSUE REPOSITORIES: THE COMMON RULE and THE HIPAA PRIVACY RULE Mark A. Rothstein, J.D. Herbert F. Boehl Chair of Law and Medicine Director, Institute.
Why Write A Grant? Elaine M. Hylek, MD, MPH Professor of Medicine Associate Director, Education and Training Division BU CTSI Section of General Internal.
Paul Kelly Facility Research Compliance Officer for the Ralph H. Johnson VA Medical Center.
Nov 26, Health-y sharing of human data. 2 Plan ahead.. It can be done in many cases, to great success and benefit!
Preliminary Findings Baseline Assessment of Scientists’ Data Sharing Practices Carol Tenopir, University of Tennessee
Virtual Hearing of the Health IT Policy Committee Clinical, Technical, Organizational and Financial Barriers to Interoperability Task Force Friday, August.
Human Subjects Update E. Wethington, Chair, UCHS.
Aalto Research Data Management Policy Ella Bingham 8 April 2016 This work is licensed under the Creative Commons Attribution 4.0 International License.
Ethics in Clinical Genetics and Genomics Key Knowledge Year 4 Medical Ethics and Law Thread Course, The Ethox Centre, University of Oxford.
UNITS 4:3-4:4 Patients’ Rights and Legal Directives for Health Care.
Big Data and Patient- Reported Outcomes: Making Sense of the Noise Mike Van Snellenberg, CTO and co-founder, Wellpepper Kristin Helps, RN, Director of.
Disclaimer This presentation is intended only for use by Tulane University faculty, staff, and students. No copy or use of this presentation should occur.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
Introduction to Health Policy and Law Jody Blanke Distinguished Professor of Computer Information Systems and Law Mercer University.
1 HIPAA’s Impact on Depository Financial Institutions 2 nd National Medical Banking Institute Rick Morrison, CEO Remettra, Inc.
European Patients’ Academy on Therapeutic Innovation Challenges in Personalised Medicine.
Patricia M. Alt, Ph.D. Dept. of Health Science Towson University
RECOGNITION OF CLINICAL TRIAL CANCER RESEARCH
Operations Director, CTRU
The factors of care that patients can expect to receive.
Pragmatic RCTs and the Learning Healthcare System
Innovative Medicines Initiative:
Phaik Yeong Cheah, B.Pharm, MSc (Bioethics), PhD
In Argentina Ana Palmero Legal and Research Ethics Advisor
Establishment of the National Biorepository in Uganda: Some Regulatory and Ethical Uncertainties Hellen Nansumba, Isaac Ssewanyana and Charles Kiyaga Central.
Chapter 13: Ethics and Law
Trial Funding and Engagement: The NIH Sponsored CTSA Program
Patient Safety Institute
Karen Ignagni President & CEO America’s Health Insurance Plans
The Legal And Ethical Concerns That Arise From Using Complex Predictive Analytics In Health Care Presenter: I. Glenn Cohen, Professor, Harvard Law School,
Presentation transcript:

Data Sharing in Health and Science: Something to Fear or Embrace? April Centre for Medical Ethics and Law University of Hong Kong Eric M. Meslin, Ph.D. Director, Indiana University Center for Bioethics Associate Dean for Bioethics, IU School of Medicine Professor of Bioethics

“The more the data banks record about each one of us, the less we exist.”

“Consumer scores – created by either the government or the private sector – threaten privacy, fairness, and due process because scores, particularly opaque scores with unknown ingredients or factors, can too easily evade the rules established to protect consumers”.

Outline Conceptual understanding of data (big and small) Data on data sharing Comment on the value of the fear vs embrace data sharing dichotomy Promising approaches for balancing privacy protection and public health promotion

Support: Collegial and Financial UL1RR /NIH Indiana Clinical and Translational Sciences Institute Pierre de Fermat Chaire d’Excellence Program, Midi-Pyrénées Regional Council, France State Grants to Promote Health Information Technology (Health Information Exchange Challenge Program) Award No: 90HT0054/01, CFDA IU Center for Law, Ethics, and Applied Research in Health Information (CLEAR) which receives funding from the Lilly Endowment, Inc. Anne Cambon-Thomsen Fred Cate Stan Crosley Brad Doebbling Ken Goodman Jane Kaye Bartha Knoppers Kimberly Quaid Josh Rager Peter Schwartz Anantha Shekhar William Tierney

“Big data refers to datasets whose size is beyond the ability of typical database software tools to capture, store, manage and analyze.” “If US healthcare were to use big data creatively and effectively to drive efficiency and quality, the sector could create more than $300 billion in value every year.”

“… the products of research [or observation], be they the mathematical calculations or findings of a quantitative intervention (e.g., the number count of patients who responded to a therapy, or the percentage of tumour reduction achieved by chemotherapy); or the experiential findings of qualitative research (e.g., the descriptions that families give of how they cope with loss).”

Data ~ Information ~ Knowledge

X 54

4.7 GB

Hospital Physician Offices Insurance Co. Hospital Billing Physician Billing WebMD Facebook YouTube Gmail PatientsLikeMe Pharmacy Google CancerNet

Physicians and Nurses—Pediatric Biobanking MD and RN attitudes toward pediatric biobanks are similar. Broad support for a pediatric biobank from HCP, including support for unspecified use of samples. Denne, Wolf, Meslin et al (2008) Women and Pregnant Mothers 77% felt predictive health research was worthwhile Most supported consent for future use Haas, Renbarger, Meslin, Drabiak, Flockhart (2006) IU Cancer Patients ~85% agreed that stored tissue could be used in unspecified future research 60-70% would not require re-contact each time tissues were used Helft, Champion, Eckles, Johnson, Meslin, (2007)

“When people in the general community were asked if they approved of their information being used in this way, they were found to be not only supportive of it, but they questioned why it was not already being done.” Stanley and Meslin (2007)

Five Big Questions 1. Who Wants Access? public, private researchers/institutions 2. What Specifically Do They Want? sensitive, identifiable, de-identified, linked 3. When Do They Want It (And For How Long)? 4. Where Will The Data Be Used? domestic or offshore 5. Why Do They Want It? research, treatment, product development

What About Researchers?

Reorganization of data files for harmonization Burdensome data retrieval Inadequate technical resources Lack of human resources Lack of financial resources Difficult to obtain permission from home institute (infrequent) Difficult to obtain permission from ethics board Tight deadline for participation Unclear data sharing policy Confidentiality of data (not frequent) Privacy of the data (not frequent) Data used for purposes not compliant with the original consent Data shared for other research purposes Data used for commercial purposes Contribution would not be recognized Data already been used for same research purposes Deadlines were too tight The data that could have been used became available too late No human resources available to submit data Project was not within the scope of own research Effort required to actually produce materials or information No incentives to deposit such data Having no place to put data Lack of standards Sponsor doesn’t require it No data management plan required by funder Long term data storage process dissatisfcation Dissatifacation with metadata tools Long term data storage support dissatisfication Data may be misinterpreted due to complexity of and poor quality of data Don’t use metadata standards Participation in another consortium Not legally possible Seen as unnecessary and time consuming Insufficient time Lack of funding too busy, too much work no longer had jurisdiction over data as had changed institutions (institution stated: too long to organize and annotate and too much work) forbidden to pass on to third parties Having received a high number of requests Trainees in high-competition labs more likely to have been denied access Perceived competition in group led to withholding info from others

Reasons, Factors and Considerations Researchers Give for Not Sharing Data Policies or Rules Prevent Data Sharing Logistical Arrangements Inhibit Data Sharing Personal, Professional Reasons Disincline Data Sharing

Policies/Rules Prevent Data Sharing Collaboration agreements with industry Conditions placed on grant awards or contracts Regulatory policies for protecting privacy

Logistical Pragmatic Arrangements Inhibit Data Sharing Insufficient protected time or human resources Insufficient infrastructure for physical transfer Inconsistent standards

Personal/Professional Reasons Disincline Data Sharing Receiving credit in publications, discoveries Fear of losing scientific edge or advantage Worries about misuse of “their” data Concern for protection of privacy/welfare of others

On the other hand...inconsistency leads to fear Researchers are interested in data sharing and recognize its importance and benefits Truth value of reasons given can be questioned An unquestioned belief in the power of technology to solve problems

“ Too little privacy can endanger democracy. But so too can too much privacy”

“Finally, at some point most patients should have an opportunity to review their medical record and to make informed choices about whether their entire record is to be available to everyone or whether certain portions of the record are privileged and should only be accessible to their principal physician or to others explicitly designated by the patient.”

Good Governance: Public Engagement Simple engagement  Provide information to public prior to consent Moderate engagement  Involve the public in discussions prior to developing a bank about policy Complex engagement  Public given authority to develop priorities for bank

Shared norms and Policy Platforms Focused on real problem Built from an evidence base Involve public and experts Grounded in good science and good ethics

410 West 10th Street, Suite 3100 Indianapolis, Indiana USA Tel: (317) Fax: (317)